Yamanaka M, Suzuki M, Sato K. Patient perspectives on research use of residual biospecimens and health information: On the necessity of obtaining societal consent by creating a governance structure based on value-sharing. Research Ethics. 2020 (in press).
Hatta T, Narita K, Yanagihara K, Ishiguro H, Murayama T, Yokode M. Crossover mixed analysis in a convergent mixed methods design used to investigate clinical dialogues about cancer treatment in the Japanese context. Journal of Mixed Methods Research. 2020; 1(14): 84-109. DOI: 10.1177/1558689818792793.
Ozeki-Hayashi R, Fujita M, Tsuchiya A, Hatta T, Nakazawa E, Takimoto Y, Akabayashi A. Beliefs held by breast surgeons that impact the treatment decision process for advanced breast cancer patients: A qualitative study. Breast cancer. 2019; 11: 221-229. DOI:10.2147/BCTT.S208910.
Sawai T, Sakaguchi H, Thomas E, Takahashi J, Fujita M. The ethics of cerebral organoid research: Being conscious of consciousness. Stem Cell Reports. 2019; 13(3): 440-447. DOI: 10.1016/j.stemcr.2019.08.003.
Sawai T, Hatta T, Fujita M. Japan significantly relaxes its human-animal chimeric embryo research regulations. Cell Stem Cell. 2019; 24(4): 513-514. DOI: 10.1016/j.stem.2019.03.015.
Prictor M, Lewis MA, Newson AJ, Haas M, Baba S, Kim H, Kokado M, Minari J, Molnár-Gábor F, Yamamoto B, Kaye J, Teare HJA. Dynamic consent: an evaluation and reporting framework. Journal of Empirical Research on Human Research Ethics. 2019; DOI: 10.1177/1556264619887073.
Hibino A, Yoshizawa G, Minari J. Meaning of ambiguity: a Japanese survey on synthetic biology and genome editing. Frontiers in Sociology. 2019; 4(81): DOI: 10.3389/fsoc.2019.00081.
Hishiyama Y, Minari J, Suganuma N. The survey of public perception and general knowledge of genomic research and medicine in Japan conducted by the Japan Agency for Medical Research and Development. Journal of Human Genetics. 2019; 64(5): 397-407. DOI: 10.1038/s10038-019-0587-3.
Takashima K, Inoue Y, Tashiro S, Muto K. Letter in reply to: ‘Therapeutic misconception and the role of the Research Ethics Committee.’ Regenerative Medicine. 2019; 14(8): DOI: 10.2217/rme-2019-0041.
